News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2011
March 9, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Emergent BioSolutions
MORE ON THIS TOPIC
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Leadership
BBOT shakes up leadership as RAS competitors get more visibility
April 23, 2026
·
2 min read
·
Annalee Armstrong
Earnings
Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change
April 23, 2026
·
3 min read
·
Annalee Armstrong
Obesity
Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’
April 23, 2026
·
2 min read
·
Tristan Manalac
